xmlui.themes.about.link
Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC): Envíos recientes
Mostrando ítems 61-80 de 230
-
Rebound activation of 5-HT neurons following SSRI discontinuation
(Nature Publishing Group, 2024) -
Oncogenic enhancers prime quiescent metastatic cells to escape NK immune surveillance by eliciting transcriptional memory
(Nature Publishing Group, 2024) -
CAFs vs. TECs: when blood feuds fuel cancer progression, dissemination and therapeutic resistance
(Springer Nature, 2024) -
El papel de la proteína HSP90 en el microambiente tumoral
(2024-04-11) -
DNA damage signalling histone H2AX is required for tumour growth
(Springer Nature, 2024) -
Soil bacterial community along an altitudinal gradient in the Sumaco, a stratovolcano in the Amazon Region
(Frontiers Media S.A., 2022) -
MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells
(Basingstoke : Nature Publishing Group, 2023) -
Enhancer-gene specificity in development and disease
(Company of Biologists Ltd., 2022-06-01) -
Risk factors in developing retinal vein occlusion in subject with obstructive sleep apnea
(Edizioni Minerva Medica, 2022) -
CD73 controls Myosin II-driven invasion, metastasis, and immunosuppression in amoeboid pancreatic cancer cells
(American Association for the Advancement of Science, 2023) -
Stromal cells regulate mechanics of tumour spheroid
(Elsevier, 2023) -
Fibroblast-derived extracellular vesicles as trackable efficient transporters of an experimental nanodrug with fibrotic heart and lung targeting
(Ivyspring International Publisher, 2024)







